Table 1

Baseline characteristics of study population

OverallInfarctNon-ischaemic CMMyocarditisNormalStress CMP value
Pt, % (no.)100 (215)22 (48)20 (42)32 (68)17 (37)9.3 (20)
Age, mean, year (SD)55 (17)63 (12)55 (14)46 (17)58 (17)62 (12)<0.001
Gender (% male)5142606349150.001
BMI, mean (SD)30 (8)31 (10)31 (9)30 (6)28 (7)29 (7)0.5
HTN (%)4863523441650.01
DM (%)10171068100.44
Current smoking (%)191526221650.28
Hyperlipidaemia (%)4050382449650.003
Prev PCI (%)885319100.06
Prev CABG (%)280005
eGFR (%) 0.09
 15–29 mL/min/1.73 m2 122005
  30–59 mL/min/1.73 m2 14132171920
  60–89 mL/min/1.73 m2 465848413550
  >90 mL/min/1.73 m2 382729514625
Mean time from troponin elevation to catheterisation, days (SD)1.13 (5)0.78 (1)0.83 (1)1.96 (8)0.86 (1)0.35 (0.5)0.51
Mean time from troponin elevation to cardiac MRI, days (SD)3.68 (6)3.56 (5)3.98 (6)3.46 (8)4.05 (5)3.45 (6)0.98
Myocardial bridging present on coronary catheterisation (%)7.408.305.907.10115.000.90
EF, %, baseline (SD)47 (17)54 (15)34 (18)50 (17)54 (12)43 (15)<0.001
EF, %, 3 months (SD)53 (14)48 (15)44 (17)59 (8)58 (8)61 (6)0.002
EF, %, 6 months (SD)52 (15)52 (15)42 (16)58 (6)64 (8)61 (9)<0.001
Discharge medications (%)
  β-blocker669076504680<0.001
  Dual antiplatelet therapy185801.501420<0.001
  ACE/ARB545283433575<0.001
  Statin538852294370<0.001
  • ARB, angiotensin-receptor blocker; BMI, body mass index; CABG, coronary artery bypass grafting; CM, cardiomyopathy; DM, diabetes mellitus; EF, ejection fraction; eGFR, estimated glomerular filtration rate; HTN, hypertension; PCI, percutaneous coronary intervention.